Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00441636
Status:
UNKNOWN
Last Update Posted:
2018-04-30
First Post:
2007-02-27
Brief Title:
Treatment Resistant Depression and Obstructive Sleep Apnea Effect of Continuous Positive Airway Pressure CPAP
Sponsor:
Queens University
Organization:
Queens University
Study Overview
Official Title:
Treatment Resistant Depression and Obstructive Sleep Apnea Effect of Treatment With CPAP on Mood Anxiety and Quality of Life
Status:
UNKNOWN
Status Verified Date:
2018-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to determine the effect on mood and anxiety symptoms of adding CPAP to the psychiatric treatment of patients with TRD treatment resistant depression and associated OSA obstructive sleep apnea
Detailed Description:
Primary objective
What is the effect on mood and anxiety symptoms of adding CPAP to the psychiatric treatment of patients with TRD and associated OSA
Secondary objectives
1 How common is co-morbid OSA in patients with treatment resistant unipolar depression referred to a tertiary Mood Disorders Clinic
2 Is there a difference in daytime functioning severity of depressive and anxiety symptoms cognitive function daytime sleepiness and sleep quality between patients with TRD diagnosed with OSA compared with patients with TRD who have no OSA
3 What is the association between sleep fragmentation and hypoxemia and the severity of depression in patients with TRD
What is the effect on mood and anxiety symptoms of adding CPAP to the psychiatric treatment of patients with TRD and associated OSA
Secondary objectives
1 How common is co-morbid OSA in patients with treatment resistant unipolar depression referred to a tertiary Mood Disorders Clinic
2 Is there a difference in daytime functioning severity of depressive and anxiety symptoms cognitive function daytime sleepiness and sleep quality between patients with TRD diagnosed with OSA compared with patients with TRD who have no OSA
3 What is the association between sleep fragmentation and hypoxemia and the severity of depression in patients with TRD
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None